Zhang Jingni, Jiang Peng, Tu Yuan, Jiang Shan, Huang Yuzhen, Li Ning, Kong Wei, Yuan Rui
Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
J Invest Surg. 2022 May;35(5):1098-1105. doi: 10.1080/08941939.2021.2013578. Epub 2021 Dec 7.
This study aimed to investigate the impact of intermediate-risk factors (IRFs) on the prognosis of stage I-II cervical cancer (CC) patients, and evaluate the necessity of adjuvant treatment based on investigation.
Medical records of 976 negative high-risk factors' CC patients were retrospectively reviewed. Clinicopathologic characteristics and adjuctive therapy were analyzed using Kaplan-Meier analysis and log-rank tests to identify significant factors. The multivariate Cox proportional hazards regression analysis was performed to identify the independent prognostic factors.
For patients with none, single and multiple IRFs, the 3-year recurrence-free survival rates were 97.8%, 86.3%, and 68.0% respectively ( < 0.001), and 3-year overall survival rates were 99.3%, 93.6% and 79.0% respectively ( < 0.001). Multivariate analysis showed histological type, differentiation grade, the number of IRFs and adjuvant therapy were independent prognostic factors.
The number of IRFs was demonstrated with higher predictive efficacy on survival of CC than individual IRF. Patients with multiple IRFs had significantly worse survival outcomes than patients with none or one. Different adjuvant treatment plans should be formulated based on the number of present IRFs. The prognostic management of patients with multiple IRFs should be pay more attention.
本研究旨在探讨中级风险因素(IRFs)对I-II期宫颈癌(CC)患者预后的影响,并在此基础上评估辅助治疗的必要性。
回顾性分析976例高危因素阴性的CC患者的病历。采用Kaplan-Meier分析和对数秩检验分析临床病理特征及辅助治疗,以确定显著因素。进行多因素Cox比例风险回归分析以确定独立预后因素。
无、单个和多个IRF的患者,3年无复发生存率分别为97.8%、86.3%和68.0%(P<0.001),3年总生存率分别为99.3%、93.6%和79.0%(P<0.001)。多因素分析显示组织学类型、分化程度、IRF数量及辅助治疗为独立预后因素。
IRF数量对CC生存的预测效能高于单个IRF。多个IRF的患者生存结局显著差于无或单个IRF的患者。应根据现有IRF数量制定不同的辅助治疗方案。对多个IRF患者的预后管理应给予更多关注。